About: Viral Vaccines in India: An Overview

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Viral Vaccines in India: An Overview Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Viral Vaccines in India: An Overview
Creator	Vrati, Sudhanshu Bharati, Kaushik
source	Medline; PMC
abstract	Viruses cause a large number of diseases in humans, some of which are fatal, while others are highly debilitating. A majority of viral diseases attack infants and young children, while others strike people in their prime. Development of preventive measures against viral diseases is, therefore, of paramount importance. Vaccination is the most cost-effective medical intervention for preventing mortality and morbidity against infectious diseases. A number of effective and safe vaccines are currently available against several viral diseases of significant medical importance. Many of these manufactured in India, are at par with international standards and are affordable. For many other viral diseases, for which vaccines are currently not available, research is underway at various national laboratories, as well as in the private sector companies in India. The present overview highlights the various vaccine preventable viral diseases that are of special importance to India and aims to provide a glimpse of the various vaccines that are currently available, or are under development in India.
has issue date	2012-01-17(xsd:dateTime)
bibo:doi	10.1007/s40011-011-0014-9
bibo:pmid	32226202
has license	no-cc
sha1sum (hex)	5d1dda983b4e851da348765ac777b82cd66569ae
schema:url	https://doi.org/10.1007/s40011-011-0014-9
resource representing a document's title	Viral Vaccines in India: An Overview
has PubMed Central identifier	PMC7100346
has PubMed identifier	32226202
schema:publication	Proc Natl Acad Sci India Sect B Biol Sci
resource representing a document's body	covid:5d1dda983b4e851da348765ac777b82cd66569ae#body_text
is schema:about of	named entity 'affordable' named entity 'viral diseases' named entity 'national laboratories' named entity 'Vaccines' named entity 'STANDARDS' named entity 'HUMANS' named entity 'OTHER VIRAL DISEASES' named entity 'CURRENTLY' named entity 'INDIA' named entity 'VACCINES' named entity 'ATTACK' named entity 'PRIVATE SECTOR' named entity 'PRIME' named entity 'MEDICAL INTERVENTION' named entity 'SAFE' named entity 'MANUFACTURED' named entity 'EFFECTIVE' named entity 'DEVELOPMENT' named entity 'VACCINE PREVENTABLE' named entity 'PEOPLE' named entity 'VIRAL VACCINES' named entity 'MEASURES' named entity 'INTERNATIONAL' named entity 'MEDICAL' named entity 'COST' named entity 'RESEARCH' named entity 'PREVENTIVE' named entity 'THESE' named entity 'TO PROVIDE' named entity 'MORBIDITY' named entity 'INFANTS' named entity 'HIGHLY' named entity 'NATIONAL LABORATORIES' named entity 'PREVENTING' named entity 'INDIA' named entity 'OVERVIEW' named entity 'THEIR' named entity 'MORTALITY' named entity 'VIRUSES' named entity 'YOUNG CHILDREN' named entity 'MAJORITY' named entity 'NOT AVAILABLE' named entity 'PAR' named entity 'SPECIAL' named entity 'DISEASES' named entity 'AVAILABLE' named entity 'COMPANIES' named entity 'CAUSE' named entity 'SIGNIFICANT' named entity 'NUMBER OF' named entity 'OVERVIEW' named entity 'VARIOUS' named entity 'AIMS' named entity 'PRESENT' named entity 'VIRAL DISEASES' named entity 'INFECTIOUS DISEASES' named entity 'LARGE' named entity 'VACCINATION' named entity 'STRIKE' named entity 'FATAL' covid:arg/5d1dda983b4e851da348765ac777b82cd66569ae named entity 'medical' named entity 'India' named entity 'large number' named entity 'humans' named entity 'paramount' named entity 'preventing' named entity 'vaccines' named entity 'private sector companies' named entity 'India' named entity 'preventive measures' named entity 'India' named entity 'vaccines' named entity 'cost-effective' named entity 'vaccines' named entity 'tetanus' named entity 'genetic information' named entity 'Phase III clinical trials' named entity 'Intercell' named entity 'tetravalent'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software